利拉鲁肽对新诊断2型糖尿病合并肥胖/超重男性病人的血睾酮水平的影响

赵琳; 刘洋; 申晶; 赵琳; 刘洋; 申晶

doi:10.13898/j.cnki.issn.1000-2200.2018.04.022

[1]

安雅莉,高研,朱倩,等.不同体重指数新诊断2型糖尿病病人胰岛素分泌和胰岛素抵抗状况调查[J].中华医学杂志,2009,89(16):1117.

[2]

中华医学会内分泌学分会.中国2型糖尿病合并肥胖综合管理专家共识[J].中华内分泌代谢杂志,2016,32(8):623.

[3]

姚亚妮,朱枣兰,王玉玲.利拉鲁肽联合盐酸二甲双胍治疗维吾尔族与汉族肥胖2型糖尿病的临床疗效[J].新疆医科大学学报,2015,36(12):1527.

[4]

SALEHI M,AULINGER BA,D'ALESSIO DA.Targeting β-cell mass in type 2 diabetes promise and limimtions of new drugs based on incretins[J].Endocr Rev,2008,29(3):367.

[5]

TENOVER JS,MATSUMOTO AM,PLYMATE SR,et al.The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion:reponse to clomiphernecitrate[J].J Clin Endocrinol Metab,1987,65(6):1118.

[6]

杜益君,潘天荣,钟兴,等.利拉鲁肽治疗不同2型糖尿病病程肥胖/超重病人的临床疗效及安全性观察[J].中国糖尿病杂志,2015,12(25):1066.

[7]

GARBER A,MATTHEWS D,ZINMAN B,et al.The effect of disease stage,indicated by number of previous oral antidiabetic[J].Diabetes,2011,60(suppl 1):967.

[8]

RAZ I,ELDOR R,CERMEA S.Diabetes:insulin resistance and derangements in lipid metabolism:Cure through intervention in fat transport and storage[J].Diabetes Metab Res Rev,2005,21(1):3.